Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
暂无分享,去创建一个
D. Rodeberg | D. Hawkins | J. Breneman | C. Arndt | S. Wolden | Yueh-Yun Chi | M. Shnorhavorian | Jing Tian | J. Routh | R. Dasgupta | D. Walterhouse
[1] A. Saltzman. Faculty Opinions recommendation of Impact of Local Control and Surgical Lymph Node Evaluation in Localized Paratesticular Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[2] James R. Anderson,et al. Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] James R. Anderson,et al. Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M. Stevens,et al. Paratesticular rhabdomyosarcoma in children and adolescents—Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studies , 2017, Pediatric blood & cancer.
[5] James R. Anderson,et al. Reduction of cyclophosphamide dose for patients with subset 2 low‐risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group , 2017, Cancer.
[6] D. Rodeberg,et al. Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study. , 2017, Journal of pediatric surgery.
[7] S. King,et al. Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial. , 2017, Radiology.
[8] A. Schuck,et al. Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the ”Cooperative Weichteilsarkom Studiengruppe” Trials CWS-86, -91, -96, and -2002P , 2016, Annals of surgery.
[9] D. Dynda,et al. Primary tumor size predicts pathologic findings in the retroperitoneal lymph nodes in patients with paratesticular rhabdomyosarcoma , 2014, Virchows Archiv.
[10] James R. Anderson,et al. Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] T. Klingebiel,et al. Impact of hemiscrotectomy on outcome of patients with embryonal paratesticular rhabdomyosarcoma: results from the Cooperative Soft Tissue Sarcoma Group Studies CWS-86, 91, 96 and 2002P. , 2014, The Journal of urology.
[12] A. Paulino,et al. Lymph node management in patients with paratesticular rhabdomyosarcoma , 2013, Cancer.
[13] S. Spunt,et al. Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas , 2013, Pediatric blood & cancer.
[14] N. Breslow,et al. Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Hawkins,et al. Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studies , 2012, Pediatric blood & cancer.
[16] James R. Anderson,et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's O , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] James R. Anderson,et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] H. B. Marsden,et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] M. Stevens,et al. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] A. Ferrari,et al. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] S. Donaldson,et al. Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? , 2001, Seminars in pediatric surgery.
[22] E. Gehan,et al. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. , 1994, Journal of pediatric surgery.
[23] M. Carli,et al. Paratesticular Rhabdomyosarcoma in Childhood: Experience of the Italian Cooperative Study , 1988, Tumori.
[24] E. Gehan,et al. Paratesticular sarcoma in childhood and adolescence: A report from the intergroup rhabdomyosarcoma studies I and II, 1973–1983 , 1987, Cancer.
[25] M. Gelfand,et al. Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging—A prospective trial , 2017, Cancer.